Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
Authors
Keywords
Allergic asthma, Allergic respiratory diseases, Anti-IgE therapy, Monoclonal anti-IgE antibody, Omalizumab, Therapy of asthma, Urticaria
Journal
MULTIDISCIPLINARY RESPIRATORY MEDICINE
Volume 9, Issue 1, Pages 23
Publisher
Springer Nature
Online
2014-04-15
DOI
10.1186/2049-6958-9-23
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Usefulness of omalizumab in ten patients with severe occupational asthma
- (2013) F. Lavaud et al. ALLERGY
- Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma
- (2013) Tomoko Tajiri et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study
- (2013) Diego Jose Maselli et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Anti-IgE – emerging opportunities for Omalizumab
- (2013) K Suresh Babu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels
- (2013) Arzu Didem Yalcin et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Omalizumab for treatment of allergic rhinitis
- (2013) Priyanka Vashisht et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy
- (2013) Matthias Volkmar Kopp et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- The eXpeRience registry: The ‘real-world’ effectiveness of omalizumab in allergic asthma
- (2013) G.-J. Braunstahl et al. RESPIRATORY MEDICINE
- The potential of biologics for the treatment of asthma
- (2012) Girolamo Pelaia et al. NATURE REVIEWS DRUG DISCOVERY
- Effects of Adding Omalizumab, an Anti-Immunoglobulin E Antibody, on Airway Wall Thickening in Asthma
- (2012) Makoto Hoshino et al. RESPIRATION
- Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010
- (2011) R. de Marco et al. EUROPEAN RESPIRATORY JOURNAL
- Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
- (2011) William W. Busse et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and tolerability of omalizumab
- (2009) J. Corren et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany
- (2009) S. Korn et al. RESPIRATORY MEDICINE
- “Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
- (2009) G. Brusselle et al. RESPIRATORY MEDICINE
- Effectiveness of omalizumab (Xolair®) in the first patients treated in real-life practice in France
- (2007) Mathieu Molimard et al. RESPIRATORY MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started